RNA Research Solutions
-
R1105 Enhanced EZ Cap™ Firefly Luciferase mRNASummary: Sequence-optimized firefly luciferase mRNA with Cap 1 structure, significantly enhances the protein expression efficiency -
R1106 Enhanced EZ Cap™ Firefly Luciferase mRNA (5-moUTP)Summary: Sequence-optimized firefly luciferase mRNA with Cap 1 structure, modified by 5-moUTP, significantly enhances the protein expression efficiency -
R1107 Enhanced EZ Cap™ Firefly Luciferase mRNA (m1Ψ)Summary: Sequence-optimized firefly luciferase mRNA with Cap 1 structure, modified by m1Ψ, significantly enhances the protein expression efficiency -
R1081 EZ Cap™ Spike mRNA (m1Ψ)Summary: SARS COV2 Spike mRNA with Cap 1 structure, modified by m1Ψ, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1108 Negative EZ Cap™ Cy5 EGFP mRNA (5-moUTP)Summary: Non-expression RNA labeled with Cy5, used as negative control -
M2016 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine sodiumSummary: A synthetic phospholipid that can be used for the preparation of liposomes -
B7953 Digoxigenin-11-UTPSummary: For transcription labeling of RNA probes used in in situ hybridization and other applications. -
B7977 5-Methyl-UTPSummary: Modified nucleoside triphosphate with methylation at the 5-carbon position of uracil, affecting RNA structure and function. -
B7978 4-Thio-UTPSummary: A nucleoside triphosphate analog with oxygen at the 4-position of uracil substituted by sulfur, commonly used in UV cross-linking studies. -
B7991 N1-Methylguanosine-5'-TriphosphateSummary: Modified nucleoside triphosphate with methylation at the N1 position of guanine, affecting RNA translation and stability.

